Contact

To discuss Elasmogen’s press release and news flow please contact info@elasmogen.com

Elasmogen CEO shortlisted for BBSRC Innovator of the Year 2019 award | 01.05.2019

Elasmogen is delighted to announce that shortlisted finalists for the 2019 BBSRC Innovator of the Year award include our CEO, Dr Caroline Barelle. The BBSRC Innovator of the Year award recognises the full breadth of impacts that BBSRC investments in research have on  lives, society and the economy. It celebrates the individuals and small teams who have […]

Almac Discovery and Elasmogen to Share Anti-ROR-1 VNAR Data at American Association of Cancer Annual Meeting | 20.03.2019

Craigavon, N.I., UK, 20 Mar 2019 – Almac Discovery, a biopharmaceutical company focused on discovering and identifying innovative therapeutics for the treatment of cancer, and Elasmogen a biotech company developing next generation therapeutic biologics, today announced they will present a poster on their VNAR-based protein drug conjugates research targeting ROR1 at the upcoming American Association […]

Elasmogen CEO Caroline Barelle Interviewed by Life Sciences Scotland for Leadership Insight | 30.01.2019

Life Sciences Scotland have interviewed Elasmogen’s CEO Caroline Barelle as part of their Insight series. The article can be accessed here.

Elasmogen Licenses NDure™ Half-life Extension Technology to ImmunoForge | 07.01.2019

Novel soloMER based albumin binder will be used for two therapeutic fusion proteins™ Aberdeen, Scotland and Seoul, Korea; January 7th 2019:  Elasmogen Ltd, developer of next generation soloMER biologics, announced today that ImmunoForge has entered a license agreement to Elasmogen’s proprietary NDure half-life extension technology for use in two non-disclosed targets.  ImmunoForge will be responsible […]

Elasmogen winner of BioFIT 2018 Start-up Slams | 07.12.2018

  Lille, 5 December 2018 – Elasmogen wins another prestigious award during the 7th Edition of BioFIT. BioFIT is one of Europe’s leading business conventions for technology transfer, academia-industry collaborations and early-stage innovations in the field of Life Sciences. It is also becoming an important marketplace for seed investment in Life Sciences by facilitating early-stage financing deals and gives participants an opportunity to access information about current events and trends in […]

Elasmogen CEO Dr Caroline Barelle wins ‘Academic Entrepreneur of the Year’ award at Entrepreneurial Scotland’s Summit Awards 2018 | 26.11.2018

Elasmogen’s CEO Dr Caroline Barelle won the Academic Entrepreneur of the Year award at Entrepreneurial Scotland’s Summit Awards ceremony which took place on 22nd November 2018 in Glasgow. Commenting on her win, Caroline says “I am delighted to be recognised for championing science-led enterprise at a national level. It is a fantastic achievement, and there […]

Summit Awards – Celebrating Scottish Entrepreneurship | 16.10.2018

Dr. Caroline Barelle, CEO of Elasmogen, is shortlisted as one of 3 finalists in the Academic to Entrepreneur of the Year category. This category recognises an individual who has demonstrated an enterprising approach to developing and delivering enterprise and entrepreneurial learning and skills, inspiring students and enabling them to realise their enterprise potential. The Academic to Entrepreneur […]

Elasmogen CEO Interviewed by Scottish Business News Network | 20.08.2018

Our CEO Caroline Barelle was interviewed by Scottish Business News Network. In her interview, Caroline discusses the journey of starting up Elasmogen and provides an insight into the ups and downs of those early days alongside a glimpse into where Elasmogen is now and the future of the company. Read the full interview here Caroline […]

Almac Discovery, Elasmogen and Innovate UK Collaborate to Develop VNAR Based Oncology Platform | 06.08.2018

£2M joint program receives grant to support research into next generation technology Craigavon, N.I., UK, 6 Aug 2018 – Almac Discovery, a biopharmaceutical company focused on discovering and identifying innovative therapeutics for the treatment of cancer, and Elasmogen, an SME focused on the development of next generation biologics, announced today that they have been awarded […]

Dr Caroline Barelle named “Rising Stars: Extraordinary Talent (2017)” at last night’s Scotland’s Life Sciences Dinner & Annual Awards. | 17.05.2018

17th May 2018: Aberdeen, Scotland: Elasmogen Ltd, developer of soloMERTM biologics, today announced that Dr Caroline Barelle was named as the winner in the “Rising Stars: Extraordinary Talent (2017)” category at last night’s Scotland’s Life Sciences Dinner & Annual Awards, held at the Hilton hotel Glasgow and attended by over 700 of Scotland’s top Life […]